4Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small cell lung cancer [J]. N Engl J Med, 2002, 346:92-98.
5Ohe Y, Ohashi Y, Kubota K, et al. Randomized phase Ⅲ study of cisplatin plus irinotecan versus earboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan[J]. Ann Oncol,2007, 18:317-323.
6Sandier AB, Gray R, Perry MC, et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small cell lung cancer [ J ]. N Engl J Med, 2006,355:2542-2550.
7Sharma SV, Bell DW, Settleman J, et al. Epidermal growth factor receptor mutations in lung cancer [ J ]. Nat Rev Cancer, 2007,7(3) :169-181.
8Hirsch FR, Varella-Garcia M, Bunn PA Jr, et al. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis[J]. J Clin Oncol, 2003,21 (20) :3798-807.
10Fukuoka M, Yano S, Giaccone G, et al. Multi-institutional randomized phase Ⅱ trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (the IDEAL1 Trial) [J]. J Clin Oncol,2003,21 (12) :2237-2246.
